This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cagliero, C.
Right arrow Articles by Payot, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cagliero, C.
Right arrow Articles by Payot, S.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, November 2006, p. 3893-3896, Vol. 50, No. 11
0066-4804/06/$08.00+0     doi:10.1128/AAC.00616-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Synergy between Efflux Pump CmeABC and Modifications in Ribosomal Proteins L4 and L22 in Conferring Macrolide Resistance in Campylobacter jejuni and Campylobacter coli{triangledown}

Cédric Cagliero, Christian Mouline, Axel Cloeckaert, and Sophie Payot*

Institut National de la Recherche Agronomique, UR1282 Infectiologie Animale et Santé Publique (IASP-213), 37380 Nouzilly, France

Received 19 May 2006/ Returned for modification 21 July 2006/ Accepted 16 August 2006

Macrolide-resistant mutants of Campylobacter jejuni and Campylobacter coli were selected in vitro using erythromycin and tylosin. These mutants exhibited modifications in the ribosomal proteins L4 (G74D) and L22 (insertions at position 86 or 98). A synergy between the CmeABC efflux pump and these modifications in conferring macrolide resistance was observed.


* Corresponding author. Mailing address: Institut National de la Recherche Agronomique, UR1282 Infectiologie Animale et Santé Publique (IASP-213), 37380 Nouzilly, France. Phone: (33) 2 47 42 79 88. Fax: (33) 2 47 42 77 74. E-mail: payot{at}tours.inra.fr.

{triangledown} Published ahead of print on 28 August 2006.


Antimicrobial Agents and Chemotherapy, November 2006, p. 3893-3896, Vol. 50, No. 11
0066-4804/06/$08.00+0     doi:10.1128/AAC.00616-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Fange, D., Nilsson, K., Tenson, T., Ehrenberg, M. (2009). Drug efflux pump deficiency and drug target resistance masking in growing bacteria. Proc. Natl. Acad. Sci. USA 106: 8215-8220 [Abstract] [Full Text]  
  • Moore, S. D., Sauer, R. T. (2008). Revisiting the mechanism of macrolide-antibiotic resistance mediated by ribosomal protein L22. Proc. Natl. Acad. Sci. USA 105: 18261-18266 [Abstract] [Full Text]  
  • Caldwell, D. B., Wang, Y., Lin, J. (2008). Development, Stability, and Molecular Mechanisms of Macrolide Resistance in Campylobacter jejuni. Antimicrob. Agents Chemother. 52: 3947-3954 [Abstract] [Full Text]  
  • Gentry, D. R., Holmes, D. J. (2008). Selection for High-Level Telithromycin Resistance in Staphylococcus aureus Yields Mutants Resulting from an rplB-to-rplV Gene Conversion-Like Event. Antimicrob. Agents Chemother. 52: 1156-1158 [Abstract] [Full Text]  
  • Gibreel, A., Wetsch, N. M., Taylor, D. E. (2007). Contribution of the CmeABC Efflux Pump to Macrolide and Tetracycline Resistance in Campylobacter jejuni. Antimicrob. Agents Chemother. 51: 3212-3216 [Abstract] [Full Text]  
  • Lin, J., Yan, M., Sahin, O., Pereira, S., Chang, Y.-J., Zhang, Q. (2007). Effect of Macrolide Usage on Emergence of Erythromycin-Resistant Campylobacter Isolates in Chickens. Antimicrob. Agents Chemother. 51: 1678-1686 [Abstract] [Full Text]